Connect Biopharma Holdings Limited Cash and Restricted Cash
Connect Biopharma Holdings Limited (CNTB) had Cash and Restricted Cash of $27.02 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.02M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $46.03M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $38.34M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $37.84M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $27.02M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $46.03M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $38.34M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $37.84M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $40.63M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $47.71M 10-Q · filed 2026-05-12 |
| 2024-12-31 | $78.23M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $97.19M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $109.84M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $114.10M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $105.66M 10-K · filed 2026-03-31 |
| 2022-12-31 | $78.95M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |